↓ Skip to main content

Psychiatry the State of the Art

Overview of attention for book
Cover of 'Psychiatry the State of the Art'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Psychometry in Early Psychopharmacology
  3. Altmetric Badge
    Chapter 2 On the Value of CNS, ANS and Behavioral Measures in Early Clinical Psychopharmacology
  4. Altmetric Badge
    Chapter 3 The Multivariate Approach in Pharmaco-EEG and ERP Research
  5. Altmetric Badge
    Chapter 4 Phase-IV Research In Psychiatry: Research Objectives And Methodology
  6. Altmetric Badge
    Chapter 5 Symptoms, Cognitions and Biology in General Practice Patients
  7. Altmetric Badge
    Chapter 6 Studies in General Practice: Interpractice Differences
  8. Altmetric Badge
    Chapter 7 The Private Practice Study Group as Phase-IV Research Tool
  9. Altmetric Badge
    Chapter 8 The Outpatient Clinic as Phase-IV Research Tool
  10. Altmetric Badge
    Chapter 9 Drug Monitoring in Psychiatric Hospitals
  11. Altmetric Badge
    Chapter 10 Psychopathology of Cognition
  12. Altmetric Badge
    Chapter 11 The Cholinergic Basis of Memory — A Reappraisal
  13. Altmetric Badge
    Chapter 12 Behavioral Effects of Vasopressin Treatment: Cognitive Implications
  14. Altmetric Badge
    Chapter 13 The Relationship between Depressive and Cognitive Disorders and Treatment with Nomifensine
  15. Altmetric Badge
    Chapter 14 Cognitive Analysis of Neuropharmacological Treatments
  16. Altmetric Badge
    Chapter 15 Is the TRH test a Predictor and Parameter of the Therapeutic Response to Antidepressive Treatment?
  17. Altmetric Badge
    Chapter 16 Some General Remarks to the Problem of Therapy Resistant Depressions
  18. Altmetric Badge
    Chapter 17 The Tyramine Pressor Test in Depressive Illness and their Treatment with Antidepressants
  19. Altmetric Badge
    Chapter 18 Biochemical Effects of Carbamazepine: Possible Mechanisms of Action in Affective and Seizure Disorders
  20. Altmetric Badge
    Chapter 19 Atypical Depression Following Maternal Deprivation
  21. Altmetric Badge
    Chapter 20 Treatment of Therapy-Resistant Depression with Drip Infusions
  22. Altmetric Badge
    Chapter 21 The Pharmacological Rationale for Bupropion
  23. Altmetric Badge
    Chapter 22 Endogenous Depression and Response to Antidepressants
  24. Altmetric Badge
    Chapter 23 Problems in the Treatment of the Chronic Depressive
  25. Altmetric Badge
    Chapter 24 Plasma Monitoring of Antidepressants
  26. Altmetric Badge
    Chapter 25 Anxiety Control without Sedation in Depressed Patients Treated with Bupropion
  27. Altmetric Badge
    Chapter 26 Weight Gain and Sexual Dysfunction during Treatment of Depression
  28. Altmetric Badge
    Chapter 27 Trazodone — A Distinctive Pharmacological Profile
  29. Altmetric Badge
    Chapter 28 Trazodone and Mianserin in General Practice
  30. Altmetric Badge
    Chapter 29 Trazodone-Induced Ventricular Arrhythmias: Fact or Artifact
  31. Altmetric Badge
    Chapter 30 Acute Trazodone Poisoning: Clinical Signs and Plasma Concentrations
  32. Altmetric Badge
    Chapter 31 The Novel Antidepressant Pirlindole: A Pharmacological Profile
  33. Altmetric Badge
    Chapter 32 About the Central Effect of Pirlindole, A New Antidepressant
  34. Altmetric Badge
    Chapter 33 The Pharmacokinetics of Pirlindole in Man
  35. Altmetric Badge
    Chapter 34 Effect of Pirlindole on Endocrine Parameters in Healthy Man
  36. Altmetric Badge
    Chapter 35 The Effect of Prilindole on the Visually Evoked Cortical Potential (VECP) in Man
  37. Altmetric Badge
    Chapter 36 Is There A Tyramine Potentiating Effect of Pirlindole?
  38. Altmetric Badge
    Chapter 37 Studies of the Effects of Pirlindole on Sleep
  39. Altmetric Badge
    Chapter 38 Placebo-Controlled Investigation on the Effects of Pirlindole on Sensorimotor Performance and Subjective Conditon in Comparison to Imipramine and Under the Influence of Ethanol
  40. Altmetric Badge
    Chapter 39 Pirlindole in Depression
  41. Altmetric Badge
    Chapter 40 Long-Term Tolerance of Pirlindole in Patients with Chronic Schizophrenia and Accompanying Depressive Symptomatology
  42. Altmetric Badge
    Chapter 41 Clinical Trials with the New Antidepressant Pirlindole in Patients with Depression and Various Psychiatric Diseases
  43. Altmetric Badge
    Chapter 42 Dosage and Efficacy of the Antidepressant Pirlindole in 15 Female In-Patients with Depressive Syndrome
  44. Altmetric Badge
    Chapter 43 Efficacy and Tolerance of Pirlindole in 20 Male In-Patients with Psychosis; Organic Brain Dysfunction and Accompanying Depression
  45. Altmetric Badge
    Chapter 44 Pirlindole: Results of an Open Clinical Study in Out-Patients and of a Double-Blind Study Against Maprotiline
  46. Altmetric Badge
    Chapter 45 Examining Pharmaco EEG-Based Predictions about the Antidepressant Action of Pirlindol by Double Blind Clinical Trials
  47. Altmetric Badge
    Chapter 46 A Double Blind Comparison of Pirlindole with Amitriptyline and Imipramine
  48. Altmetric Badge
    Chapter 47 A Double-Blind Comparative Study of Pirlindole and Amitriptyline in 30 Depressive Patients
  49. Altmetric Badge
    Chapter 48 A Comparison of Pirlindole and Amitriptyline in a Double-Blind Controlled Study
  50. Altmetric Badge
    Chapter 49 EEG Changes Induced by Amitriptyline and Pirlindole in Endogenous Depression
  51. Altmetric Badge
    Chapter 50 A Double-Blind Comparative Study on the Use of 225 Mg Pirlindole and 150 Mg Desipramine in the Treatment of Depressive Inpatients
  52. Altmetric Badge
    Chapter 51 Antidepressive Efficacy of Pirlindole in Man
  53. Altmetric Badge
    Chapter 52 Effect of a Single Dose of 225 Mg Pirlindole on Intraocular Pressure and Diameter of Pupils in 10 Patients with Eye Diseases without Primary Raise in Intraocular Pressure
  54. Altmetric Badge
    Chapter 53 Psychopharmacology of Suicide: The Background
  55. Altmetric Badge
    Chapter 54 The Prevention of Attempts in High Risk Suicidal Patients
  56. Altmetric Badge
    Chapter 55 Thyrotropin Response to Thyreostimulin and Suicidal Behaviour
  57. Altmetric Badge
    Chapter 56 Cerebrospinal Fluid Amine Metabolites and Neuroendocrine Findings: Biochemical Markers in Suicide?
  58. Altmetric Badge
    Chapter 57 Introduction to Psychotic Disorders Responsive to Lithium
  59. Altmetric Badge
    Chapter 58 A Biological Test Which Distinguishes Lithium Responsive Psychoses
  60. Altmetric Badge
    Chapter 59 The Use of Lithium in the Long Term Morbidity Suppressive Treatment of Cycloid and Schizoaffective Psychoses
  61. Altmetric Badge
    Chapter 60 Li-Responsive Psychosis: Family Studies
  62. Altmetric Badge
    Chapter 61 Psychotic Disorders Responsive to Lithium: Clinical Features
  63. Altmetric Badge
    Chapter 62 Lithium Ratio and Lithium Response in the Psychoses
  64. Altmetric Badge
    Chapter 63 Membranes, Lipids and the Lithium-Responsive Psychoses
  65. Altmetric Badge
    Chapter 64 Lithium Withdrawal Triggers Psychosis
  66. Altmetric Badge
    Chapter 65 Lithium Discontinuation: Side-Effects, Withdrawl Symptoms, Rebound Effect
  67. Altmetric Badge
    Chapter 66 What Follows Lithium Withdrawal?
  68. Altmetric Badge
    Chapter 67 New Approaches to the Treatment of Lithium Non-Responders
  69. Altmetric Badge
    Chapter 68 RBC-Choline: Relation to Clinical Lithium Response
  70. Altmetric Badge
    Chapter 69 On the Interaction Carbamazepine with Catecholamine Metabolism: Implication for Psychopharmacological and Behavioural Effects
  71. Altmetric Badge
    Chapter 70 Effect of Valproate on In Vivo GABA-Turnover
  72. Altmetric Badge
    Chapter 71 The Use of Valproate and Oxcarbazepine in Affective Disorders
  73. Altmetric Badge
    Chapter 72 Efficacy of Valproate in Manic-Depressive Psychosis: Mechanism of Action and Implications for Pathophysiology
  74. Altmetric Badge
    Chapter 73 Therapeutic and Prophylactic Efficacy of Carbamazepine in Affective Disorders
  75. Altmetric Badge
    Chapter 74 Prophylactic Efficacy of Carbamazepine in Affective Disorders
  76. Altmetric Badge
    Chapter 75 Carbamazepine: Treatment of Affective Illness and Anxiety Syndromes
  77. Altmetric Badge
    Chapter 76 Carbamazepine in Excited Psychoses
  78. Altmetric Badge
    Chapter 77 Prophylactic Treatment of Affective Disorders with Carbamazepine and Oxcarbazepine: An Open Clinical Trial
  79. Altmetric Badge
    Chapter 78 Oxcarbazepine in Acute Mania
  80. Altmetric Badge
    Chapter 79 Calcium Antagonists in Mania: A Preliminary Clinical Report
  81. Altmetric Badge
    Chapter 80 Pet-Investigation in Anorexia Nervosa: Preliminary Results
  82. Altmetric Badge
    Chapter 81 The GABA System of the Mammalian CNS
  83. Altmetric Badge
    Chapter 82 Benzodiazepine Receptor: Structural Aspects and Modes of Ligand Interactions
  84. Altmetric Badge
    Chapter 83 Interactions of Benzodiazepines with the GABA System
  85. Altmetric Badge
    Chapter 84 Usefulness and Limitations of Benzodiazepine Pharmacokinetics for Clinical Practice
  86. Altmetric Badge
    Chapter 85 Brain Receptor Occupation and Kinetics of Benzodiazepine Action
  87. Altmetric Badge
    Chapter 86 Alternatives to Minor Tranquillizers in Depression
  88. Altmetric Badge
    Chapter 87 Therapeutic Alternatives in Depression
  89. Altmetric Badge
    Chapter 88 Therapeutic Alternatives in Psychosomatic Cardiovascular Disorders
  90. Altmetric Badge
    Chapter 89 Therapeutic Alternatives in Other Psychosomatic Disorders
  91. Altmetric Badge
    Chapter 90 Alternatives to Treatment with Minor Tranquilizers in Adolescent Patients
  92. Altmetric Badge
    Chapter 91 Alternatives to Treatment with Minor Tranquilizers in Psychogeriatrics
  93. Altmetric Badge
    Chapter 92 Alternatives to Treatment with Minor Tranquillisers in Organic Diseases
  94. Altmetric Badge
    Chapter 93 Introduction to the Symposium “Recent Developments in Substituted Benzamide Drugs”
  95. Altmetric Badge
    Chapter 94 Selective Actions of Substituted Benzamide Drugs on Brain Dopamine Receptors
  96. Altmetric Badge
    Chapter 95 Neuroleptics and Drug-Induced Modifications of Behaviour in Animals and Men
  97. Altmetric Badge
    Chapter 96 The Dopaminergic Receptors and their Interaction with Neuroleptics and Benzamide Compounds
  98. Altmetric Badge
    Chapter 97 Bipolar Effects of Sulpiride
  99. Altmetric Badge
    Chapter 98 Present Use of Sultopride in Psychiatry
  100. Altmetric Badge
    Chapter 99 Double Blind Study to Compare Activity and Tolerance of Sultopride and Haloperidol in Agitated States: Report on 46 Cases
  101. Altmetric Badge
    Chapter 100 Sultopride in the Treatment of Psychiatric Disorders in Children and Adolescents
  102. Altmetric Badge
    Chapter 101 Clinical Experience in the Treatment of Tardive Dyskinesia with Tiapride
  103. Altmetric Badge
    Chapter 102 Tiapride Treatment in Extrapyramidal Disorders and in Pain Syndromes
  104. Altmetric Badge
    Chapter 103 Treatment of Acute Withdrawl Syndrome with Tiapride
  105. Altmetric Badge
    Chapter 104 Tiapride and Chlormethiazole in Alcohol Withdrawal: A Double-Blind Trial
  106. Altmetric Badge
    Chapter 105 Determination of Pharmacokinetics and Pharmacodynamics of Amisulpride by Pharmaco-EEG and Psychometry
  107. Altmetric Badge
    Chapter 106 A Double Blind Comparison of Amisulpride vs. Haloperidol in Acute Schizophrenic Patients
  108. Altmetric Badge
    Chapter 107 Clinical Evaluation of Prosulpride in Depressive States
  109. Altmetric Badge
    Chapter 108 Effects of Sulpiride in Schizophrenic Patients
  110. Altmetric Badge
    Chapter 109 Substituted Benzamides in the Treatment of Acute Oneiric and Confusional Psychoses
  111. Altmetric Badge
    Chapter 110 Combined or Sequential Use of Sulpiride and Sultopride-Intravenous Administration of Sulpiride
  112. Altmetric Badge
    Chapter 111 Conclusion of the Symposium “Recent Developments in Substituted Benzamide Drugs”
  113. Altmetric Badge
    Chapter 112 Pharmacokinetics of Oral and Depot Neuroleptics
  114. Altmetric Badge
    Chapter 113 CIS(Z)-Clopenthixol in the Treatment of Acute Schizophrenia
  115. Altmetric Badge
    Chapter 114 The Management of the Schizophrenic Patient in the U.K. “Model Unit” in Community Psychiatry Worcester
  116. Altmetric Badge
    Chapter 115 Maintenance Treatment of Chronic Schizophrenia
  117. Altmetric Badge
    Chapter 116 Is Additional Medication Required in the Maintenance Treatment of Schizophrenia?
  118. Altmetric Badge
    Chapter 117 Effect of Neuroleptic Withdrawal during the Maintenance Treatment of Chronic Schizophrenics
  119. Altmetric Badge
    Chapter 118 A Double–Blind Controlled Clinical Trial of Haloperidol Decanoate and Fluphenazine Decanoate in the Maintenance Treatment of Schizophrenia
  120. Altmetric Badge
    Chapter 119 Depot-Neuroleptics in Acute Psychiatry
  121. Altmetric Badge
    Chapter 120 Depot Neuroleptics as Tranquilizers
  122. Altmetric Badge
    Chapter 121 Biochemical and Neuroendocrinological Effects of Chronic Neuroleptic Treatment
  123. Altmetric Badge
    Chapter 122 Demands and Expectations of Depotneuroleptics in Social Psychiatry
  124. Altmetric Badge
    Chapter 123 Pharmacology of Fluperlapine Compared with Clozapin
  125. Altmetric Badge
    Chapter 124 NB 106 – 689 (FLUPERLAPINE) In 104 Schizophrenic Patients (Open Multicenter Trial)
  126. Altmetric Badge
    Chapter 125 Anxiety or Depression: Which should you treat? The Unmasking and Treatment of Anxiety in Depression
  127. Altmetric Badge
    Chapter 126 Relapses of Manic-Depressive Disorders Triggered By Abrupt Lithium Withdrawal
  128. Altmetric Badge
    Chapter 127 The Challenge of Lithium Discontinuation
  129. Altmetric Badge
    Chapter 128 Carbamazepine in Violent Schizophrenics
  130. Altmetric Badge
    Chapter 129 The Use of Valpromide in Affective Disorders (Acute and prophylactic therapies)
  131. Altmetric Badge
    Chapter 130 Comparative Studies of the Effect of Carbamazepin and Trimipramin on Depressions
  132. Altmetric Badge
    Chapter 131 Carbamazepine: A Possible Alternative in Lithium-Resistant Bipolar Disorder
Overall attention for this book and its chapters
Altmetric Badge

Mentioned by

blogs
1 blog
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Psychiatry the State of the Art
Published by
Springer US, December 2012
DOI 10.1007/978-1-4613-2363-1
ISBNs
978-1-4612-9446-7, 978-1-4613-2363-1
Editors

Pichot, P., Berner, P., Wolf, R., Thau, K.